Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Post by princeofcuton Aug 18, 2015 9:47am
135 Views
Post# 24027245

RVX vs. ESPR leadership matters...

RVX vs. ESPR leadership matters.....you all should listen to the ESPR webcast from yesterday...


...ESPR has a great relationship with the FDA and is moving quickly to an FDA PIII LDL trial that will not be a huge study...hmmmmmm...what was RVX CEO spouting earlier

...why hasn't RVX been able to gain FDA clearance yet on its supposed PIII???

..and worse how did RVX let the ESPR brainiacs get away??? big failure there

..unlike someone posted earlier leadership really does matter...ESPR = Major league all-stars RVX = Junior C League 4th line...
Bullboard Posts